Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips Expands Augmented Reality Surgical Navigation ? Clarifeye ? to Two New International Sites with Successful Clinical Outcomes

12/01/2021 | 04:00am EST

Royal Philips announced that the first patients have been successfully treated using its innovative 3D Augmented Reality (AR) spine navigation solution at Sant Joan de D?u Barcelona Children's Hospital, Spain, and the Armed Forces Hospital, Oman. For both cases the surgeons used Philips integrated Spine Suite solution that offers the company?s Azurion Hybrid Operating Room (OR) with ClarifEye, an industry-first solution that combines 2D and 3D visualisations at low X-ray dose with 3D AR navigation into one system. This enables surgeons to define and navigate along the critical pathway using this advanced real-time image guidance for precise device placement both in open and minimally invasive spine procedures. The first patient treated with ClarifEye at Sant Joan de D?u Barcelona Children's Hospital involved open image guided surgery on a 12-year-old patient with severe congenital spondylolisthesis, a condition where the spine is misaligned due to a defect in one of the joints. Without treatment, it can affect quality of life and increase the risk of several chronic conditions. Using the Philips? spine solution, pedicle screws were successfully placed at four spine levels to fuse several lumbar vertebras.


ę S&P Capital IQ 2021
All news about PHILIPS NV
12:28pJefferies Downgrades Koninklijke Philips to Hold from Buy, Lowers Price Target to 32 Eu..
MT
09:43aPhilips supports the American Heart Association's efforts to raise awareness of cardiov..
AQ
04:34aPHILIPS NV : Bernstein reiterates its Buy rating
MD
02:11aPHILIPS NV : Jefferies gives a Neutral rating
MD
01/19Philips supports the American Heart Association's efforts to raise awareness of cardiov..
AQ
01/18Philips to Collaborate With Cydar on Image-Guided Endovascular Surgery
MT
01/18Royal Philips Signs Strategic Partnership With Cydar
MT
01/18Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series &n..
AQ
01/18Philips Integrates Cloud-Based AI and 3D Mapping into Mobile C-Arm System Series –..
CI
01/14HSBC Upgrades Koninklijke Philips to Buy from Hold, Lowers Price Target to 38 Euros Fro..
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 323 M 19 605 M 19 605 M
Net income 2021 3 406 M 3 854 M 3 854 M
Net Debt 2021 4 250 M 4 809 M 4 809 M
P/E ratio 2021 7,57x
Yield 2021 2,93%
Capitalization 25 690 M 29 130 M 29 074 M
EV / Sales 2021 1,73x
EV / Sales 2022 1,62x
Nbr of Employees 77 084
Free-Float 95,8%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 30,01 €
Average target price 41,14 €
Spread / Average Target 37,1%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-8.42%29 157
THERMO FISHER SCIENTIFIC-11.56%233 816
DANAHER CORPORATION-12.76%205 105
INTUITIVE SURGICAL, INC.-18.32%104 835
SIEMENS HEALTHINEERS AG-9.69%75 669
EDWARDS LIFESCIENCES CORPORATION-10.34%72 523